Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR
EMD Serono senior scientist Carina Carter shares her experience with some of the latest immunoassay technology optimizing pharmacokinetics and immunogenicity assay development
RHB-107 is a novel serine protease inhibitor targeting human cell factors involved in viral entry, and is therefore expected to be effective against emerging viral variants with mutations in the spike protein
Discover the latest technologies and techniques to aid research into the biology, detection, and prevention of SARS-CoV-2 infection
Find out how to overcome the challenges involved with establishing reference intervals for clinical interpretation in this on-demand webinar
New partnership broadens access to oncology treatments across Latin America, Asia, Africa and the Western Pacific
The test could be used to assess antibody response against the native spike protein of SARS-CoV-2 following COVID-19 vaccination
Arvind Kothandaraman discusses the importance of detecting new SARS-CoV-2 variants and future trends in COVID-19 diagnostics
This effort will study virus variants in the UK and South Africa and what that means for the transmission of SARS-CoV-2
Expanded list of instruments and reagents allows more options for labs running CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay
In this on-demand webinar, discover how to rapidly diagnose antimicrobial resistance for appropriate therapy
Cabenuva allows virologically suppressed adults with HIV to maintain viral suppression with 12 dosing days per year
The strategic collaboration aims to accelerate clinical trials and drive critical developments for promising COVID-19 treatments
The new research center is to receive some 30 million Swiss Francs financial support from the Vinetum Foundation over a period of 10 years
Panel supports research to distinguish between types of chronic inflammatory airway disease including asthma, COPD and IPF
The integrated solution offers deeper insight into therapy resistance and relapse, saving billions in drug development costs
Precision dosing of the liquid therapy is very important as it must correspond to each patient’s addiction level
These findings are crucial as rapidly spreading variants of SARS-CoV-2 have been reported in various countries
Working with the UK government, first vaccinations are to begin early in the new year
Take a look back at the technologies, innovations and clinical advances that hit the headlines over the past 12 months
Elecsys Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS- CoV-2 spike protein
Explore ways to improve time to result in critical pathways such as sepsis
